0.086
price down icon22.52%   -0.025
after-market Dopo l'orario di chiusura: .08 -0.006 -6.98%
loading
Precedente Chiudi:
$0.111
Aprire:
$0.0917
Volume 24 ore:
18.89M
Relative Volume:
0.60
Capitalizzazione di mercato:
$3.32M
Reddito:
$4.02M
Utile/perdita netta:
$-4.73M
Rapporto P/E:
-0.0204
EPS:
-4.21
Flusso di cassa netto:
$-5.85M
1 W Prestazione:
+17.81%
1M Prestazione:
-16.34%
6M Prestazione:
-75.43%
1 anno Prestazione:
-94.19%
Intervallo 1D:
Value
$0.086
$0.0964
Intervallo di 1 settimana:
Value
$0.0542
$0.23
Portata 52W:
Value
$0.0542
$1.48

Petros Pharmaceuticals Inc Stock (PTPI) Company Profile

Name
Nome
Petros Pharmaceuticals Inc
Name
Telefono
973-242-0005
Name
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
Name
Ultimi documenti SEC
Name
PTPI's Discussions on Twitter

Confronta PTPI con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Drug Manufacturers - Specialty & Generic icon
PTPI
Petros Pharmaceuticals Inc
0.086 3.32M 4.02M -4.73M -5.85M -4.21
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
163.11 73.07B 9.26B 2.49B 2.30B 5.47
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
15.05 47.43B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.24 45.72B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
15.08 17.28B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
ITCI
Intra Cellular Therapies Inc
131.81 14.03B 612.78M -86.37M -62.91M -0.87

Petros Pharmaceuticals Inc Borsa (PTPI) Ultime notizie

pulisher
Mar 28, 2025

Pre-market Movers: PRTG, RNAZ, PTIX, LGMK... - RTTNews

Mar 28, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

Pre-market Movers: RGLS, SLNO, OCEA, OSRH... - RTTNews

Mar 27, 2025
pulisher
Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Mar 27, 2025
pulisher
Mar 27, 2025

3 Penny Stocks to Watch Now, 3/27/25 - TipRanks

Mar 27, 2025
pulisher
Mar 27, 2025

Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 27, 2025
pulisher
Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Is Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) the Best AI Stock to Invest in According to Reddit? - Yahoo Finance

Mar 26, 2025
pulisher
Mar 26, 2025

Nasdaq Down 1%; Dollar Tree To Sell Family Dollar Business For $1 Billion - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Mar 26, 2025
pulisher
Mar 26, 2025

Why GameStop Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga

Mar 26, 2025
pulisher
Mar 25, 2025

Is Apellis Pharmaceuticals, Inc. (APLS) a Promising Biotech Stock According to Wall Street Analysts - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Petro-Victory Energy Corp Announces Extension to US $1,700,000 Note - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Is Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) The Best Extremely Profitable Stocks to Buy According to Analyst? - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

CNS Pharmaceuticals Announces Primary Analysis of Berubicin in Second Line Treatment of Glioblastoma Multiforme - Yahoo Finance

Mar 25, 2025
pulisher
Mar 25, 2025

Innovations In Medical Technology And Materials Drive Advancements In Erectile Dysfunction Treatments: Key ... - WhaTech

Mar 25, 2025
pulisher
Mar 24, 2025

EXCLUSIVE: MIRA Pharmaceuticals Signs To Acquire SKNY Pharmaceuticals, Expand Pipeline Into Weight Loss And Smoking Cessation Drug - Yahoo Finance

Mar 24, 2025
pulisher
Mar 21, 2025

Acurx Pharmaceuticals (ACXP) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Petros Pharmaceuticals enters collaboration with big data, analytics firm - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Petros Pharmaceuticals enhances Rx-to-OTC switch technology By Investing.com - Investing.com South Africa

Mar 20, 2025
pulisher
Mar 20, 2025

Petros Pharmaceuticals enhances Rx-to-OTC switch technology - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications - ACCESS Newswire

Mar 20, 2025
pulisher
Mar 20, 2025

Petros Pharmaceuticals Targets $38B Self-Care Market with Game-Changing AI Drug Platform - StockTitan

Mar 20, 2025
pulisher
Mar 18, 2025

PTPI stock plunges to 52-week low of $0.07 amid market challenges By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

PTPI stock plunges to 52-week low of $0.07 amid market challenges - Investing.com Australia

Mar 18, 2025
pulisher
Mar 17, 2025

Nvidia GTC 2025: What to expect from Nvidia's biggest event of the year - Yahoo Finance

Mar 17, 2025
pulisher
Mar 10, 2025

PTPI’s price-to-free cash flow ratio: How it affects investment decisions - US Post News

Mar 10, 2025
pulisher
Mar 10, 2025

Regeneron Pharmaceuticals, Inc. (REGN): Hedge Funds Are Bullish On This Oversold Blue Chip Stock Now - Yahoo Finance

Mar 10, 2025
pulisher
Mar 07, 2025

Petro-Victory Energy and BlueOak Investments to acquire Capixaba Energia - Yahoo Finance

Mar 07, 2025
pulisher
Mar 05, 2025

TCBP Announces Non-Binding Letter of Intent to Acquire Commercial Stage Ophthalmic Pharmaceutical Company - Yahoo Finance

Mar 05, 2025
pulisher
Mar 02, 2025

Entrada Therapeutics, Inc. Just Beat EPS By 55%: Here's What Analysts Think Will Happen Next - Yahoo Finance

Mar 02, 2025
pulisher
Feb 28, 2025

Internationally Published, Head-to-Head Data From India of Petros Pharmaceuticals' STENDRA(R) (Avanafil) Tablets Reported Improvement in Erectile Function Compared to Sildenafil and Baseline After 12 Weeks of Therapy - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Pharma Stock Roundup: LLY Ups U.S. Manufacturing Investments & More - Yahoo Finance

Feb 28, 2025
pulisher
Feb 27, 2025

Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022 - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

New FDA-Approved Labeling for Petros Pharmaceuticals’ STENDRA (avanafil) Now Includes Efficacy Data Regarding Use in Men Who Have Undergone Radical Prostatectomy - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 26, 2025

Petros Pharmaceuticals stock hits 52-week low at $0.1 By Investing.com - Investing.com South Africa

Feb 26, 2025
pulisher
Feb 26, 2025

Petros Pharmaceuticals stock hits 52-week low at $0.1 - Investing.com

Feb 26, 2025
pulisher
Feb 25, 2025

Artificial Intelligence (AI) News Live Feed - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Petros reports success in AI-assisted Rx-to-OTC study - Investing.com India

Feb 25, 2025
pulisher
Feb 25, 2025

Petros reports success in AI-assisted Rx-to-OTC study By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study - ACCESS Newswire

Feb 25, 2025
pulisher
Feb 25, 2025

Can Petros Pharmaceuticals' AI-Powered Platform Revolutionize the $38B Self-Care Market? - StockTitan

Feb 25, 2025
pulisher
Feb 24, 2025

BioCryst Pharmaceuticals Inc (BCRX) Q4 2024 Earnings Call Highlights: Strong ORLADEYO Revenue ... - Yahoo Finance

Feb 24, 2025
pulisher
Feb 23, 2025

Recursion Pharmaceuticals, Inc. (RXRX): The Best Performing Pharma Stock So Far in 2025? - Yahoo Finance

Feb 23, 2025
pulisher
Feb 21, 2025

PTPI Page Not Found - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Why Viking Therapeutics Inc. (VKTX) Surged On Friday? - Yahoo Finance

Feb 21, 2025
pulisher
Feb 20, 2025

Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025 - Yahoo Finance

Feb 20, 2025
pulisher
Feb 19, 2025

Petros Pharmaceuticals announces pricing of $9.6 million public offering - MSN

Feb 19, 2025
pulisher
Feb 19, 2025

Form 424B4 Petros Pharmaceuticals, - StreetInsider.com

Feb 19, 2025
pulisher
Feb 18, 2025

PTPI stock plunges to 52-week low of $0.15 amid market challenges - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings - Benzinga

Feb 18, 2025

Petros Pharmaceuticals Inc Azioni (PTPI) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$10.41
price down icon 3.70%
$33.21
price down icon 0.95%
$96.16
price down icon 0.91%
$8.68
price down icon 1.81%
$113.16
price down icon 0.74%
$131.81
price up icon 0.05%
Capitalizzazione:     |  Volume (24 ore):